Cargando…

Deletion Mutants of Human Deoxycytidine Kinase mRNA in Cells Resistant to Antitumor Cytosine Nucleosides

We studied mutational events in deoxycytidine (dCyd) kinase mRNA expression, focusing on aberrant dCyd kinase mRNA, which has been frequently observed in established cell lines resistant to antitumor dCyd nucleoside analogues such as 1‐β‐D‐arabinofuranosyl cytosine (Ara‐C), gemcita‐bine (dFdC) and 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obata, Tohru, Endo, Yoshio, Tanaka, Motohiro, Uchida, Hiroyuki, Matsuda, Akira, Sasaki, Takuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2001
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926779/ https://www.ncbi.nlm.nih.gov/pubmed/11473731 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01163.x

Ejemplares similares

Antitumor Effect of Sugar-Modified Cytosine Nucleosides on Growth of Adult T-Cell Leukemia Cells in Mice
por: Maeda, Naoyoshi, et al.
Publicado: (2020)

Antitumor Activity and Pharmacokinetics of TAS‐106, l‐(3‐C‐Ethynyl‐β‐D‐ribo‐pentofuranosyl)cytosine
por: Shimamoto, Yuji, et al.
Publicado: (2001)

Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
por: Richel, D. J., et al.
Publicado: (1988)

A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression
por: Meike, Shunsuke, et al.
Publicado: (2011)

Structural basis for activation of the therapeutic l-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase
por: Sabini, Elisabetta, et al.
Publicado: (2007)

Redesigning Human 2′-Deoxycytidine Kinase Enantioselectivity for l-Nucleoside Analogues as Reporters in Positron Emission Tomography
por: Muthu, Pravin, et al.
Publicado: (2014)

Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine
por: Koduvayur, Sujatha P., et al.
Publicado: (2016)

A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
por: Santos, Sean M., et al.
Publicado: (2019)

A Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-β-D-Ribo-Pentofuranosyl)Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton Beam
por: Maeda, Kenichiro, et al.
Publicado: (2016)

Inverse Correlation between mRNA Expression of Plasminogen Activator Inhibitor‐2 and Lymph Node Metastasis in Human Breast Cancer
por: Ishikawa, Noboru, et al.
Publicado: (1996)

Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2
por: Shimamoto, Yuji, et al.
Publicado: (2002)

Human equilibrative nucleoside transporter‐1 and deoxycytidine kinase can predict gemcitabine effectiveness in Egyptian patients with Hepatocellular carcinoma
por: Attia, Fadia, et al.
Publicado: (2020)

Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106
por: Shimamoto, Yuji, et al.
Publicado: (2002)

The α-d-anomer of 2′-deoxycytidine: crystal structure, nucleoside conformation and Hirshfeld surface analysis
por: Budow-Busse, Simone, et al.
Publicado: (2021)

Comparative Transcriptomics of H. pylori Strains AM5, SS1 and Their hpyAVIBM Deletion Mutants: Possible Roles of Cytosine Methylation
por: Kumar, Ritesh, et al.
Publicado: (2012)

Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase
por: Coulibaly, Safiatou T., et al.
Publicado: (2015)

Synthesis and Antiviral Evaluation of 3′-Fluoro-5′-norcarbocyclic Nucleoside Phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents
por: Geant, Pierre-Yves, et al.
Publicado: (2020)

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene
por: Galmarini, Carlos María, et al.
Publicado: (2004)

Antioxidant Activity of a Series of Fluorinated Pyrano-nucleoside Analogues of N(4)-benzoyl Cytosine and N(6)-benzoyl Adenine
por: Spanou, Chrysoula, et al.
Publicado: (2007)

Experimental Metastasis of Oncogene‐transformed NIH 3T3 Cells in Chick Embryo
por: Endo, Yoshio, et al.
Publicado: (1992)

A Mutant of Uracil DNA Glycosylase That Distinguishes between Cytosine and 5-Methylcytosine
por: Kimber, Scott T., et al.
Publicado: (2014)

5-aza-2′,2′-Difluroro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer
por: Daifuku, Richard, et al.
Publicado: (2017)

Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
por: Ding, Yuedi, et al.
Publicado: (2020)

Antioxidant and Antitumor Activities of New Synthesized Aromatic C-Nucleoside Derivatives
por: El Sadek, Mohamed M., et al.
Publicado: (2014)

High Guanine and Cytosine Content Increases mRNA Levels in Mammalian Cells
por: Kudla, Grzegorz, et al.
Publicado: (2006)

Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6
por: Selmi, Tommaso, et al.
Publicado: (2020)

Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress
por: Hewish, M, et al.
Publicado: (2013)

Targeted enzyme prodrug therapy for metastatic prostate cancer – a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase
por: Guillen, Katrin P, et al.
Publicado: (2014)

Zebrafish AID is capable of deaminating methylated deoxycytidines
por: Abdouni, Hala, et al.
Publicado: (2013)

Intragenomic Decarboxylation of 5‐Carboxy‐2′‐deoxycytidine
por: Kamińska, Ewelina, et al.
Publicado: (2021)

Cytosine Unstacking and Strand Slippage at an Insertion–Deletion Mutation Sequence in an Overhang-Containing DNA Duplex
por: Manjari, Swati R., et al.
Publicado: (2014)

The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells
por: Cheng, Huiying, et al.
Publicado: (2021)

Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents
por: Klanova, Magdalena, et al.
Publicado: (2014)

O-2-Alkylated Cytosine Acyclic Nucleoside Phosphonamidate Prodrugs Display Pan-Genotype Antiviral Activity against African Swine Fever Virus
por: Goulding, Leah V., et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Novel Allobetulon/Allobetulin–Nucleoside Conjugates as AntitumorAgents
por: Wang, Yanli, et al.
Publicado: (2022)

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.
por: Okamoto, S., et al.
Publicado: (1996)

Chick Embryo Assay as Chemosensitivity Test for Malignant Glioma
por: Shoin, Katsuo, et al.
Publicado: (1991)

THE PATTERNS OF LABELING OF GERMINAL-CENTER CELLS WITH TRITIATED DEOXYCYTIDINE
por: Osogoe, Bunsuke, et al.
Publicado: (1973)

Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5‐Aza‐2′‐deoxycytidine
por: Shichijo, Shigeki, et al.
Publicado: (1996)

Arabidopsis thaliana nucleosidase mutants provide new insights into nucleoside degradation
por: Riegler, Heike, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9aruqec1aob01l6fievf82q6lb